Ignite Creation Date:
2024-05-05 @ 9:42 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00000650
Status:
COMPLETED
Last Update Posted:
2021-10-27
First Post:
1999-11-02
Brief Title:
An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate DTC in HIV-Infected Patients
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Study Overview
Official Title:
An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate DTC in HIV-Infected Patients
Status:
COMPLETED
Status Verified Date:
2021-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine in HIV-infected patients the magnitude and duration of the biological effects of ditiocarb sodium sodium diethyldithiocarbamate DTC that may be relevant to treatment of HIV infection
DTC has been studied in previous clinical trials in HIV-infected patients with the suggestion of delay in disease progression to AIDS and improvement in CD4 counts while on the drug
DTC has been studied in previous clinical trials in HIV-infected patients with the suggestion of delay in disease progression to AIDS and improvement in CD4 counts while on the drug
Detailed Description:
DTC has been studied in previous clinical trials in HIV-infected patients with the suggestion of delay in disease progression to AIDS and improvement in CD4 counts while on the drug
Two groups of patients one group asymptomatic and the other with AIDS diagnosis are enrolled in the study All patients receive DTC intravenously once a week for two weeks Drugs are given on days 1 and 8 Blood samples are drawn on days 1 3 5 8 10 and 12
Two groups of patients one group asymptomatic and the other with AIDS diagnosis are enrolled in the study All patients receive DTC intravenously once a week for two weeks Drugs are given on days 1 and 8 Blood samples are drawn on days 1 3 5 8 10 and 12
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 11141 | REGISTRY | DAIDS ES Registry Number | None |